Intérêt du rituximab dans les syndromes de Sjögren...

Intérêt du rituximab dans les syndromes de Sjögren réfractaires. Expérience monocentrique

F. Thouy, A.-L. Fauchais, G. Gondran, L. Magy, M. Essig, H. Bézanahary, V. Loustaud-Ratti, K.-H. Ly, P. Manea, E. Vidal-Cathala
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Year:
2009
Language:
french
DOI:
10.1016/j.revmed.2009.10.361
File:
PDF, 86 KB
french, 2009
Conversion to is in progress
Conversion to is failed